Drug offers speedier recovery of Covid-19 patients

SOME PATIENTS admitted to hospital with Covid-19 are to be given access to the drug remdesivir, which has been shown to shorten recovery time.

Doctors will now be able to prescribe the drug to adults and adolescents who have severe Covid-19 infection where there is a likelihood it will benefit them.

The Department of Health and Social Care said the UK Government is working with manufacturer Gilead Sciences to supply remdesivir treatment to some NHS patients.

The Respiratory Clinical Trials Unit in Hull is one of the centres which runs a trial of remdesivir.

Earlier this month, a global clinical trial, which is continuing, found that remdesivir cut the length of time people suffered symptoms from 15 days to 11.

The trial involves around 1,000 patients from hospitals including the UK, US, France, Italy and China. Remdesivir is an anti-viral medicine that was originally developed to fight Ebola.

Innovation Minister Lord Bethell said: “This shows fantastic progress. As we navigate this unprecedented period, we must be on the front foot of the latest medical advancements, while always ensuring patient safety remains a top priority.

“The latest expert scientific advice is at the heart of every decision we make, and we will continue to monitor remdesivir’s success in clinical trials across the country to ensure the best results for UK patients.”

Separately, the World Health Organisation’s (WHO) decision to temporarily halt trials of hydroxychloroquine as a potential coronavirus treatment has been welcomed by UK experts.

On Monday, WHO directorgeneral Tedros Adhanom Ghebreyesus said the decision had been taken in light of a paper published last week in the Lancet.

Experts found that hydroxychloroquine – and a related medicine chloroquine – was linked to an increased risk of death and heart arrhythmias among people severely ill in hospital with coronavirus.

US President Donald Trump has been criticised after he said he had nothing to lose by taking hydroxychloroquine, which is used to treat malaria.